SCHEMBL8934119

SCHEMBL8934119

CCCCCOc1ccc(-c2ccc(-c3ccc(C4CCC(CCCCC)CC4)c(F)c3)cc2)c(F)c1F

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 8/20 0.34
PTPN11 Q06124 3/20 0.34
FFAR4 Q5NUL3 2/20 0.34
FPR2 P25090 1/20 0.34
S1PR1 P21453 1/20 0.34
DGAT1 O75907 1/20 0.33
SCN9A Q15858 1/20 0.33
RARA P10276 1/20 0.33
RARB P10826 1/20 0.33
PTPN1 P18031 1/20 0.32
PTPN6 P29350 1/20 0.32
TLR9 Q9NR96 1/20 0.32
TLR8 Q9NR97 1/20 0.32
TLR7 Q9NYK1 1/20 0.32
AVPR2 P30518 1/20 0.32
AVPR1A P37288 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8934244 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934223 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934246 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934153 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934249 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934028 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934039 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934130 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934291 0.99 PTPN11 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1
SCHEMBL8934128 0.98 S1PR1 (0.35) OPRL1PTPN11FFAR4FPR2S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8187494-B2 Four- or five-ring liquid crystal compound having lateral fluorine, liquid crystal composition, and liquid crystal display device JNC CORPORATION (JP) 2012-05-29 US disclosed